FDA report raises concerns over attention-deficit drugs
‘Twenty-five people died and 54 more suffered serious cardiovascular problems after taking drugs to treat attention deficit hyperactivity disorder between 1999 and 2003, the government says.
Children accounted for 19 of the deaths and 26 of the cases of non-fatal cardiovascular problems, including heart attack, stroke, hypertension, palpitations and arrhythmia, according to a Food and Drug Administration report released Wednesday.
The FDA report also includes data on another 26 deaths between 1969 and 2003 in ADHD drug patients. Those include death by suicide, intentional overdose, drowning, heat stroke and from underlying disease.’
Read more at FDA report raises concerns over attention-deficit drugs
Recent Entries
- Sigma Pharmaceuticals year profit rises 27 pct
- South African citizens cheap drug guinea pigs
- Two drugs test victims face a year in coma
- Can drug companies improve their reputation?
- Pfizer Sees 40 Percent Rise in 2006 Net on Cost Cuts
- Pfizer’s Forecast Disappoints
- Pharmaceutical RFID Adoption Stalls
- Inhalable Drug Might Bring Sigh Of Relief To Diabetes Patients
- GlaxoSmithKline unveils best results since merger
- Pfizer Sues Teva, Sandoz Over Zithromax